Welcome to the Atrial Fibrillation Ablation Registry's Educational Overview. The content in this presentation was developed and provided by Caroline Morgan and Christina Kutras. I am John Jarratt, and I will be narrating this presentation. The objectives for this registry overview are for the learner to be able to define the purpose of the AFib ablation registry and effects of atrial fibrillation, describe registry inclusion population and the role of registry governance, and identify primary AFib ablation procedure goals. The mission of the American College of Cardiology is to transform cardiovascular care and improve heart health. The vision is a world where innovation and knowledge optimize cardiovascular care and outcomes. The Atrial Fibrillation Ablation Registry is designed to assess the prevalence, demographics, management, and outcomes of patients undergoing percutaneous catheter ablation procedures to treat atrial fibrillation. Patient-level data is submitted by participating hospitals on a quarterly basis to the American College of Cardiology Foundation's National Cardiovascular Data Registry, or NCDR. The primary aims of the AFib ablation registry are to optimize the outcomes and management of patients through the implementation of evidence-based guideline recommendations in clinical practice, facilitate efforts to improve the quality and safety for patients undergoing percutaneous catheter ablation procedures, investigate novel quality improvement methods and provide risk-adjusted assessment of patients for comparison with nationwide NCDR data. The secondary purpose of the AFib ablation registry is to serve as a rich source of clinical data to support assessments of short- and long-term safety, comparative and cost-effectiveness research, and as a scalable data infrastructure for post-market studies. Atrial fibrillation is a growing health concern of population health. Greater than 5.1 million people in the United States are affected by atrial fibrillation. It is anticipated that the reported volume of AFib will increase by three times by the year 2050. Greater than 750,000 hospitalizations occur each year due to AFib, with over 130,000 deaths per year. The medical costs for patients with AFib in the U.S. every year are about $8,705 higher for people who have AFib than those who don't have the dysrhythmia. The likelihood that an asymptomatic AFib patient has or will have a stroke is 14.7% compared with 6% of symptomatic patients. These numbers are staggering, and the AFib registry is a tool to monitor evidence-based treatment, safety, and long-term outcomes. The inclusion population for the AFib ablation registry is anyone 18 years of age or older who has had an attempted percutaneous catheter-based AFib ablation procedure. If the AFib ablation procedure is performed in combination with another type of ablation procedure, the patient should still be included in the registry. The AFib ablation registry is an evidence-based tool for data collection with the primary objective of improving quality of life. The long-term objective of the registry being decreased and or elimination of medication burden and to decrease the risk of bleeding by eliminating the need for blood thinners. Additional benefits and objectives of the procedure include decreased fatigue experienced by the patient, lowered risk of stroke and the development of heart failure, and increased tolerance for exercise and activities of daily living. As a nationally recognized surveillance tool, the AFib ablation registry is well positioned within the healthcare industry to support ongoing quality improvement efforts for patients having these procedures. The AFib ablation registry provides hospitals feedback on their data in comparison to the registry benchmark on a weekly basis through an interactive dashboard and quarterly through published outcomes reports. The data can support the hospital's internal process and quality improvement efforts and provides timely insights into the adherence to performance measures and guideline care. The AFib ablation registry has become a tool for outside stakeholders, healthcare system states and payers who use it to assess the incidence and trends of AFib ablation procedures and the quality of care provided by providers and the centers engaged in these procedures. It supports numerous research initiatives, informs clinical practice and guideline development. Additionally, registry data can be used to support ACC Accreditation Services EP accreditation. The AFib ablation registry is governed by a 7-10 member steering committee with a chair and ex-officio member and CDR management board. Committee members have expertise in clinical practice, financial management, quality measurement and improvement and or health system strategy and innovation. The steering committee provides strategic oversight and direction. Guidance for program activities and research insights help to identify priorities. Committee recommendations are provided to the NCDR management board and help inform this committee's decisions. This concludes the overview of the AFib ablation registry. Thank you for your participation.

Atrial Fibrillation Ablation Registry

AFib ablation registry

percutaneous catheter ablation procedures

atrial fibrillation treatment

clinical data